Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35026540)

  • 1. Mutations and clinical significance of calcium voltage-gated channel subunit alpha 1E (CACNA1E) in non-small cell lung cancer.
    Gao SH; Wang GZ; Wang LP; Feng L; Zhou YC; Yu XJ; Liang F; Yang FY; Wang Z; Sun BB; Wang D; Liang LJ; Xie DW; Zhao S; Feng HP; Li X; Li KK; Tang TS; Huang YC; Wang SQ; Zhou GB
    Cell Calcium; 2022 Mar; 102():102527. PubMed ID: 35026540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional expression of the voltage-gated Na⁺-channel Nav1.7 is necessary for EGF-mediated invasion in human non-small cell lung cancer cells.
    Campbell TM; Main MJ; Fitzgerald EM
    J Cell Sci; 2013 Nov; 126(Pt 21):4939-49. PubMed ID: 23986482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypoxia-inducible factor-1α and nuclear factor-κB play important roles in regulating programmed cell death ligand 1 expression by epidermal growth factor receptor mutants in non-small-cell lung cancer cells.
    Guo R; Li Y; Wang Z; Bai H; Duan J; Wang S; Wang L; Wang J
    Cancer Sci; 2019 May; 110(5):1665-1675. PubMed ID: 30844110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer.
    Sunaga N; Imai H; Shimizu K; Shames DS; Kakegawa S; Girard L; Sato M; Kaira K; Ishizuka T; Gazdar AF; Minna JD; Mori M
    Int J Cancer; 2012 Apr; 130(8):1733-44. PubMed ID: 21544811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
    Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
    Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 variant-dependent regulation of redox balance in EGFR mutation-positive non-small cell lung cancer: A target for treatment.
    Kawano Y; Iwama E; Tsuchihashi K; Shibahara D; Harada T; Tanaka K; Nagano O; Saya H; Nakanishi Y; Okamoto I
    Lung Cancer; 2017 Nov; 113():72-78. PubMed ID: 29110853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine activates cell-signaling pathways through muscle-type and neuronal nicotinic acetylcholine receptors in non-small cell lung cancer cells.
    Carlisle DL; Liu X; Hopkins TM; Swick MC; Dhir R; Siegfried JM
    Pulm Pharmacol Ther; 2007; 20(6):629-41. PubMed ID: 17015027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium channel α2δ1 subunit is a functional marker and therapeutic target for tumor-initiating cells in non-small cell lung cancer.
    Ma Y; Yang X; Zhao W; Yang Y; Zhang Z
    Cell Death Dis; 2021 Mar; 12(3):257. PubMed ID: 33707423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of Fn14 in non-small cell lung cancer correlates with activated EGFR and promotes tumor cell migration and invasion.
    Whitsett TG; Cheng E; Inge L; Asrani K; Jameson NM; Hostetter G; Weiss GJ; Kingsley CB; Loftus JC; Bremner R; Tran NL; Winkles JA
    Am J Pathol; 2012 Jul; 181(1):111-20. PubMed ID: 22634180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer.
    Sunaga N; Kaira K; Imai H; Shimizu K; Nakano T; Shames DS; Girard L; Soh J; Sato M; Iwasaki Y; Ishizuka T; Gazdar AF; Minna JD; Mori M
    Oncogene; 2013 Aug; 32(34):4034-42. PubMed ID: 22964644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic identification of CDC34 that functions to stabilize EGFR and promote lung carcinogenesis.
    Zhao XC; Wang GZ; Wen ZS; Zhou YC; Hu Q; Zhang B; Qu LW; Gao SH; Liu J; Ma L; Zhang YF; Zhang C; Yu H; Zhang DL; Wang M; Wang CL; Huang YC; Liu ZH; Zhao Y; Chen L; Zhou GB
    EBioMedicine; 2020 Mar; 53():102689. PubMed ID: 32114396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible Involvement of the CACNA1E Gene in Migraine: A Search for Single Nucleotide Polymorphism in Different Clinical Phenotypes.
    Ambrosini A; D'Onofrio M; Buzzi MG; Arisi I; Grieco GS; Pierelli F; Santorelli FM; Schoenen J
    Headache; 2017 Jul; 57(7):1136-1144. PubMed ID: 28573794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of NEK2 promotes lung cancer progression and drug resistance and is regulated by mutant EGFR.
    Chen C; Peng S; Li P; Ma L; Gan X
    Mol Cell Biochem; 2020 Dec; 475(1-2):15-25. PubMed ID: 32761510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
    Gong H; Li Y; Yuan Y; Li W; Zhang H; Zhang Z; Shi R; Liu M; Liu C; Chen C; Liu H; Chen J
    BMC Cancer; 2020 Dec; 20(1):1189. PubMed ID: 33276757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer.
    Zhu J; Cai T; Zhou J; Du W; Zeng Y; Liu T; Fu Y; Li Y; Qian Q; Yang XH; Li Q; Huang JA; Liu Z
    J Exp Clin Cancer Res; 2021 Jun; 40(1):192. PubMed ID: 34108040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between epidermal growth factor receptor (EGFR) mutation and serum cyclooxygenase-2 Level, and the synergistic effect of celecoxib and gefitinib on EGFR expression in non-small cell lung cancer cells.
    Li N; Li H; Su F; Li J; Ma X; Gong P
    Int J Clin Exp Pathol; 2015; 8(8):9010-20. PubMed ID: 26464643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of dihydropyrimidine dehydrogenase in lung adenocarcinoma is associated with mutations in epidermal growth factor receptor: implications for the treatment of non--small-cell lung cancer using 5-fluorouracil.
    Mochinaga K; Tsuchiya T; Nagasaki T; Arai J; Tominaga T; Yamasaki N; Matsumoto K; Miyazaki T; Nanashima A; Hayashi T; Tsukamoto K; Nagayasu T
    Clin Lung Cancer; 2014 Mar; 15(2):136-144.e4. PubMed ID: 24405586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational activation of the epidermal growth factor receptor down-regulates major histocompatibility complex class I expression via the extracellular signal-regulated kinase in non-small cell lung cancer.
    Watanabe S; Hayashi H; Haratani K; Shimizu S; Tanizaki J; Sakai K; Kawakami H; Yonesaka K; Tsurutani J; Togashi Y; Nishio K; Ito A; Nakagawa K
    Cancer Sci; 2019 Jan; 110(1):52-60. PubMed ID: 30390416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mechanism of erlotinib resistance in epidermal growth factor receptor mutant non-small cell lung cancer cell line H1650].
    Han R; Wang X; Zhong D; Zhao J; Chen Z; Sun L; Wang J; Zhang J
    Zhongguo Fei Ai Za Zhi; 2012 Dec; 15(12):689-93. PubMed ID: 23249714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.